Zanganeh Mahkam
SEC insider (Form 3/4/5 filer). CIK 0001507650. Director at PULSE BIOSCIENCES, INC. (PLSE) and 1 other issuer. 22 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in MIAMI, FL.
Companies Zanganeh Mahkam has filed insider reports for
- PULSE BIOSCIENCES, INC. (PLSE): Director
- Summit Therapeutics Inc. (SMMT): Director, Officer, 10% Owner, Co-Chief Executive Officer
Zanganeh Mahkam
CIK: 0001507650
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 12, 2026SMMT
Summit Therapeutics Inc.
PurchaseIndirect3.8M shares at avg. $13.12$50.0M - Jun 11, 2026PLSE
PULSE BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
14.5K shares- - Jun 11, 2026PLSE
PULSE BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
30K shares- - Jun 4, 2026SMMT
Summit Therapeutics Inc.
PurchaseIndirect100K shares at avg. $14.60$1.5M - Jan 2, 2026SMMT
Summit Therapeutics Inc.
AwardIndirectStock Option (right to buy)
11.2K shares at avg. $8.76- - Oct 21, 2025SMMT
Summit Therapeutics Inc.
AwardIndirect14M shares at avg. $18.74$262.0M - Oct 21, 2025SMMT
Summit Therapeutics Inc.
AwardIndirect266.8K shares at avg. $18.74$5.0M - Oct 21, 2025SMMT
Summit Therapeutics Inc.
PurchaseIndirect26.7K shares at avg. $18.74$500K - Sep 11, 2025SMMT
Summit Therapeutics Inc.
PurchaseIndirect5K shares at avg. $18.07$90K - Sep 10, 2025SMMT
Summit Therapeutics Inc.
PurchaseIndirect333.4K shares at avg. $17.68$5.9M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  SMMT Summit Therapeutics Inc. | Purchase | 3,810,000 | $13.12 | $49,987,200 | Indirect |
| Jun 11, 2026 |  PLSE PULSE BIOSCIENCES, INC. | Award Stock Option (right to buy) | 14,504 | - | - | Direct |
| Jun 11, 2026 | PLSE PULSE BIOSCIENCES, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jun 4, 2026 | SMMT Summit Therapeutics Inc. | Purchase | 100,000 | $14.60 | $1,460,000 | Indirect |
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 11,232 | $8.76 | - | Indirect |
| Oct 21, 2025 | SMMT Summit Therapeutics Inc. | Award | 13,980,789 | $18.74 | $261,999,986 | Indirect |
| Oct 21, 2025 | SMMT Summit Therapeutics Inc. | Award | 266,808 | $18.74 | $4,999,982 | Indirect |
| Oct 21, 2025 | SMMT Summit Therapeutics Inc. | Purchase | 26,680 | $18.74 | $499,983 | Indirect |
| Sep 11, 2025 | SMMT Summit Therapeutics Inc. | Purchase | 5,000 | $18.07 | $90,350 | Indirect |
| Sep 10, 2025 | SMMT Summit Therapeutics Inc. | Purchase | 333,394 | $17.68 | $5,894,406 | Indirect |
1-10 of 22 transactions